{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:31:29Z","timestamp":1778113889618,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.urology.2010.07.461","type":"journal-article","created":{"date-parts":[[2010,10,26]],"date-time":"2010-10-26T04:45:34Z","timestamp":1288068334000},"page":"1518.e1-1518.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Exposure of Human Seminal Vesicle Tissue to Phosphodiesterase (PDE) Inhibitors Antagonizes the Contraction Induced by Norepinephrine and Increases Production of Cyclic Nucleotides"],"prefix":"10.1016","volume":"76","author":[{"given":"Ponco","family":"Birowo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"\u00dcckert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George T.","family":"Kedia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim E.","family":"Sonnenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Sandner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter F.","family":"Thon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friedemann","family":"Scheller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Djoko","family":"Rahardjo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus A.","family":"Kuczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2010.07.461_bib1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1464-410X.2007.07051.x","article-title":"A review of the current status of topical treatments for premature ejaculation","volume":"100","author":"Morales","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2010.07.461_bib2","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.1743-6109.2008.00831.x","article-title":"Premature ejaculation: current medical treatment and new directions","volume":"5","author":"Sadeghi-Nejad","year":"2008","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2010.07.461_bib3","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.eururo.2006.05.055","article-title":"Serotonin and premature ejaculation: from physiology to patient management","volume":"50","author":"Giuliano","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2010.07.461_bib4","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.eururo.2009.01.025","article-title":"Dapoxetine for the treatment of premature ejaculation: results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries","volume":"55","author":"Buvat","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2010.07.461_bib5","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1464-410X.2008.08165.x","article-title":"Treatment benefit of dapoxetine for premature ejaculation: results from a placebo-controlled phase III trial","volume":"103","author":"Kaufman","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2010.07.461_bib6","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S1359-6446(05)03596-8","article-title":"Can smooth muscle represent a useful target for the treatment of rapid ejaculation?","volume":"10","author":"Abdel-Hamid","year":"2005","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.urology.2010.07.461_bib7","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0090-4295(02)01534-0","article-title":"Effects of various nitric oxide donating agents on the contractility and cyclic nucleotide turnover of human seminal vesicles in vitro","volume":"59","author":"Heuer","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.urology.2010.07.461_bib8","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0090-4295(02)02165-9","article-title":"Effects of various nitric oxide-donating drugs on adrenergic tension of human seminal vesicles in vitro","volume":"61","author":"Machtens","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.urology.2010.07.461_bib9","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s00240-003-0322-5","article-title":"Immunocytochemical distribution of nitric oxide synthase in the human seminal vesicle: a light and electron microscopical study","volume":"31","author":"\u00dcckert","year":"2003","journal-title":"Urol Res"},{"key":"10.1016\/j.urology.2010.07.461_bib10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.urology.2007.02.049","article-title":"Functional responses of isolated human seminal vesicle tissue to selective phosphodiesterase inhibitors","volume":"70","author":"\u00dcckert","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.urology.2010.07.461_bib11","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1743-6109.2008.01085.x","article-title":"Effects of phosphodiesterase inhibitors on the contractile responses of isolated human seminal vesicle tissue to adrenergic stimulation","volume":"6","author":"\u00dcckert","year":"2009","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2010.07.461_bib12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003495-200464010-00002","article-title":"Phosphodiesterase 5 inhibitors in rapid ejaculation: potential use and possible mechanisms of action","volume":"64","author":"Abdel-Hamid","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.urology.2010.07.461_bib13","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1743-6109.2005.20351.x","article-title":"Efficacy of sildenafil citrate (Viagra) in men with premature ejaculation","volume":"2","author":"McMahon","year":"2005","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2010.07.461_bib14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1439-0272.2008.00910.x","article-title":"Safety and efficacy of vardenafil versus sertraline in the treatment of premature ejaculation: a randomized, prospective and cross-over study","volume":"41","author":"Mathers","year":"2009","journal-title":"Andrologia"},{"key":"10.1016\/j.urology.2010.07.461_bib15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ijir.2009.21","article-title":"Effects of vardenafil administration on intravaginal ejaculatory latency time in men with lifelong premature ejaculation","volume":"21","author":"Aversa","year":"2009","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.urology.2010.07.461_bib17","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0021-9258(18)57021-6","article-title":"Determination of serum proteins by means of the biuret reaction","volume":"177","author":"Gornall","year":"1949","journal-title":"J Biol Chem"},{"key":"10.1016\/j.urology.2010.07.461_bib18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1468-3083.2004.00885.x","article-title":"Update on the oral treatments for male erectile dysfunction","volume":"18","author":"Kalsi","year":"2004","journal-title":"Eur Academy Dermatol Venereol"},{"key":"10.1016\/j.urology.2010.07.461_bib19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s003450100221","article-title":"Phosphodiesterase 1 inhibition in the treatment of lower urinary tract dysfunction: from bench to bedside","volume":"19","author":"Truss","year":"2001","journal-title":"World J Urol"},{"key":"10.1016\/j.urology.2010.07.461_bib20","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.juro.2007.07.048","article-title":"Vardenafil improves urodynamic parameters in men with spinal cord injury: results from a single dose, pilot study","volume":"178","author":"Gacci","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2010.07.461_bib21","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.juro.2006.10.055","article-title":"sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial","volume":"177","author":"McVary","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2010.07.461_bib22","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.juro.2006.11.037","article-title":"Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"177","author":"McVary","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2010.07.461_bib23","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.eururo.2008.01.075","article-title":"A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"53","author":"Stief","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2010.07.461_bib24","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1097\/01.ju.0000090966.74607.34","article-title":"Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: a double-blind, placebo-controlled study","volume":"170","author":"Berman","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2010.07.461_bib25","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/BF01268862","article-title":"Is glandular formation of nitric oxide a prerequisite for muscarinic secretion of fructose in the guinea-pig seminal vesicle?","volume":"25","author":"Ehren","year":"1997","journal-title":"Urol Res"},{"key":"10.1016\/j.urology.2010.07.461_bib26","first-page":"23","article-title":"Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine","volume":"3","author":"Katsuki","year":"1977","journal-title":"J Cyclic Nucleotide Res"},{"key":"10.1016\/j.urology.2010.07.461_bib27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF00182035","article-title":"Ejaculatory failure","volume":"11","author":"Witt","year":"1993","journal-title":"World J Urol"},{"key":"10.1016\/j.urology.2010.07.461_bib28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1054\/mehy.2001.1296","article-title":"A bihormonal model of normal sexual stimulation; the etiology of premature ejaculation","volume":"57","author":"Motofei","year":"2001","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.urology.2010.07.461_bib29","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1442-2042.2007.01606.x","article-title":"Can sildenafil treat premature ejaculation?","volume":"14","author":"Wang","year":"2007","journal-title":"Int J Urol"},{"key":"10.1016\/j.urology.2010.07.461_bib30","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S0960-894X(02)00190-7","article-title":"Discovery of L-791.943: a potent, selective, non-emetic and orally active phosphodiesterase 4 inhibitor","volume":"12","author":"Guay","year":"2002","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.urology.2010.07.461_bib31","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0022-3565(25)23992-1","article-title":"Cyclic GMP potentiation by win 58237, a novel cyclic nucleotide phosphodiesterase inhibitor","volume":"271","author":"Silver","year":"1997","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429510014494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429510014494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:54:45Z","timestamp":1758765285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429510014494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0090429510014494"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2010.07.461","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.7863956.8211054","asserted-by":"object"}]},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exposure of Human Seminal Vesicle Tissue to Phosphodiesterase (PDE) Inhibitors Antagonizes the Contraction Induced by Norepinephrine and Increases Production of Cyclic Nucleotides","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2010.07.461","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}